Abdulrahman A Alsuhibani (Abdulrahman Alsuhibani)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Network Analysis

Prognostic Factors

Patient Reported Outcomes

Top Venues

Obesity surgery

Pharmaceuticals (Basel, Switzerland)

Healthcare (Basel, Switzerland)

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulrahman A Alsuhibani, Omar A Al-Obeed, Patricia R Wigle, Mohammed M Alsultan, Jeff J Guo, Alex C Lin, Marepalli B Rao, Ana L Hincapie
Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012-2021 Electronic Medical Records Network Data. Obesity surgery 34 (4) (2024)
Abdulrahman A Alsuhibani, Omar A Al-Obeed, Patricia R Wigle, Mohammed M Alsultan, Jeff J Guo, Alex C Lin, Marepalli B Rao, Ana L Hincapie
Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012-2021 Electronic Medical Records Network Data. Obesity surgery (2024)
Marwan A Alrasheed, Khalid A Alamer, Mashael Albishi, Abdulrahman A Alsuhibani, Omar A Almohammed, Abdulrahman M Alwhaibi, Abdullah N Almajed, Jeff J Guo
Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Abdulrahman A Alsuhibani, Omar A Al-Obeed, Patricia R Wigle, Mohammed M Alsultan, Jeff J Guo, Alex C Lin, Marepalli B Rao, Ana L Hincapie
Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012-2021 Electronic Medical Records Network Data. Obesity surgery 34 (4) (2024)
Marwan A Alrasheed, Khalid A Alamer, Mashael Albishi, Abdulrahman A Alsuhibani, Omar A Almohammed, Abdulrahman M Alwhaibi, Abdullah N Almajed, Jeff J Guo
Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Marwan A Alrasheed, Khalid A Alamer, Mashael Albishi, Abdulrahman A Alsuhibani, Omar A Almohammed, Abdulrahman M Alwhaibi, Abdullah N Almajed, Jeff J Guo
Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Abdulrahman A Alsuhibani, Omar A Al-Obeed, Patricia R Wigle, Mohammed M Alsultan, Jeff J Guo, Alex C Lin, Marepalli B Rao, Ana L Hincapie
Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012-2021 Electronic Medical Records Network Data. Obesity surgery 34 (4) (2024)
Abdulrahman A Alsuhibani, Omar A Al-Obeed, Patricia R Wigle, Mohammed M Alsultan, Jeff J Guo, Alex C Lin, Marepalli B Rao, Ana L Hincapie
Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012-2021 Electronic Medical Records Network Data. Obesity surgery 34 (4) (2024)
Marwan A Alrasheed, Abdulrahman A Alsuhibani, Bander Balkhi, Jeff Jianfei Guo
Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022. Healthcare (Basel, Switzerland) 11 (16) (2023)
Abdulrahman A Alsuhibani, Marwan Alrasheed, Musaab Gari, Ana L Hincapie, Jeff Jianfei Guo
Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013-2020. International journal of clinical pharmacy (2021)